Across TCGA pan-cancer cohorts, STAU2P1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated STAU2P1 data layer compared with 14 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher STAU2P1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated STAU2P1 expression acts as an unfavorable survival marker.

OV are the cancer types where STAU2P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	II,III,IV	0.174	0.541	.009	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: STAU2P1 tumor-vs-normal RNA expression · all STAU2P1 data types